These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 29613769)

  • 1. Protein-Protein Interactions in the Molecular Chaperone Network.
    Freilich R; Arhar T; Abrams JL; Gestwicki JE
    Acc Chem Res; 2018 Apr; 51(4):940-949. PubMed ID: 29613769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.
    Carver JA; Ecroyd H; Truscott RJW; Thorn DC; Holt C
    Acc Chem Res; 2018 Mar; 51(3):745-752. PubMed ID: 29442498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors and chemical probes for molecular chaperone networks.
    Gestwicki JE; Shao H
    J Biol Chem; 2019 Feb; 294(6):2151-2161. PubMed ID: 30213856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHIP: a co-chaperone for degradation by the proteasome.
    Edkins AL
    Subcell Biochem; 2015; 78():219-42. PubMed ID: 25487024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
    Hervás R; Oroz J
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone-client complexes: A dynamic liaison.
    Hiller S; Burmann BM
    J Magn Reson; 2018 Apr; 289():142-155. PubMed ID: 29544626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperones and chaperone-substrate complexes: Dynamic playgrounds for NMR spectroscopists.
    Burmann BM; Hiller S
    Prog Nucl Magn Reson Spectrosc; 2015 Apr; 86-87():41-64. PubMed ID: 25919198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp70 chaperone: a master player in protein homeostasis.
    Fernández-Fernández MR; Valpuesta JM
    F1000Res; 2018; 7():. PubMed ID: 30338057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interactions of molecular chaperones with client proteins: why are they so weak?
    Arhar T; Shkedi A; Nadel CM; Gestwicki JE
    J Biol Chem; 2021 Nov; 297(5):101282. PubMed ID: 34624315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying chaperone-mediated transitions in the proteostasis network of E. coli.
    Dickson A; Brooks CL
    PLoS Comput Biol; 2013; 9(11):e1003324. PubMed ID: 24244134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular chaperone functions in protein folding and proteostasis.
    Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
    Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional Chaperone-Client Interactions Revealed by Genetically Encoded Photo-cross-linkers.
    Zhang S; He D; Lin Z; Yang Y; Song H; Chen PR
    Acc Chem Res; 2017 May; 50(5):1184-1192. PubMed ID: 28467057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple functionalities of molecular chaperones revealed through systematic mapping of their interaction networks.
    Rizzolo K; Houry WA
    J Biol Chem; 2019 Feb; 294(6):2142-2150. PubMed ID: 30194284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Patterns in Chaperone Interactions with a Native Client Protein.
    He L; Hiller S
    Angew Chem Int Ed Engl; 2018 May; 57(20):5921-5924. PubMed ID: 29498447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Profiling of Chaperone/Client Interactions with LUMIER Assay.
    Taipale M
    Methods Mol Biol; 2018; 1709():47-58. PubMed ID: 29177650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery.
    Wang L; Xu X; Jiang Z; You Q
    Acta Pharm Sin B; 2020 Oct; 10(10):1904-1925. PubMed ID: 33163343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.
    Wang L; Bergkvist L; Kumar R; Winblad B; Pavlov PF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivalent protein-protein interactions are pivotal regulators of eukaryotic Hsp70 complexes.
    Johnson OT; Gestwicki JE
    Cell Stress Chaperones; 2022 Jul; 27(4):397-415. PubMed ID: 35670950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.